Literature DB >> 27799302

Proliferating Helper T Cells Require Rictor/mTORC2 Complex to Integrate Signals from Limiting Environmental Amino Acids.

Lee-Ann Van de Velde1,2, Peter J Murray3,2.   

Abstract

Antigen-stimulated T cells require elevated importation of essential and non-essential amino acids to generate large numbers of daughter cells necessary for effective immunity to pathogens. When amino acids are limiting, T cells arrest in the G1 phase of the cell cycle, suggesting that they have specific sensing mechanisms to ensure sufficient amino acids are available for multiple rounds of daughter generation. We found that activation of mTORC1, which is regulated by amino acid amounts, was uncoupled from limiting amino acids in the G1 phase of the cell cycle. Instead, we found that Rictor/mTORC2 has an essential role in T cell amino acid sensing. In the absence of Rictor, CD4+ T cells proliferate normally in limiting arginine or leucine. Our data suggest that Rictor/mTORC2 controls an amino acid-sensitive checkpoint that allows T cells to determine whether the microenvironment contains sufficient resources for daughter cell generation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  T helper cells; amino acid; immunology; immunosuppression; mTOR complex (mTORC)

Mesh:

Substances:

Year:  2016        PMID: 27799302      PMCID: PMC5207057          DOI: 10.1074/jbc.C116.763623

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  The restriction point of the cell cycle.

Authors:  Mikhail V Blagosklonny; Arthur B Pardee
Journal:  Cell Cycle       Date:  2002 Mar-Apr       Impact factor: 4.534

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

3.  Amino Acids Regulate mTORC1 by an Obligate Two-step Mechanism.

Authors:  Julia Dyachok; Svetlana Earnest; Erica N Iturraran; Melanie H Cobb; Elliott M Ross
Journal:  J Biol Chem       Date:  2016-09-01       Impact factor: 5.157

4.  The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.

Authors:  Ewan M Smith; Stephen G Finn; Andrew R Tee; Gareth J Browne; Christopher G Proud
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

5.  Stress Kinase GCN2 Controls the Proliferative Fitness and Trafficking of Cytotoxic T Cells Independent of Environmental Amino Acid Sensing.

Authors:  Lee-Ann Van de Velde; Xi-Zhi J Guo; Lidija Barbaric; Amber M Smith; Thomas H Oguin; Paul G Thomas; Peter J Murray
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

Review 6.  Amino acid auxotrophy as a system of immunological control nodes.

Authors:  Peter J Murray
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

7.  T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming.

Authors:  Kai Yang; Sharad Shrestha; Hu Zeng; Peer W F Karmaus; Geoffrey Neale; Peter Vogel; David A Guertin; Richard F Lamb; Hongbo Chi
Journal:  Immunity       Date:  2013-12-05       Impact factor: 31.745

8.  Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.

Authors:  P Brennan; J W Babbage; B M Burgering; B Groner; K Reif; D A Cantrell
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

9.  Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway.

Authors:  Robert A Saxton; Kevin E Knockenhauer; Rachel L Wolfson; Lynne Chantranupong; Michael E Pacold; Tim Wang; Thomas U Schwartz; David M Sabatini
Journal:  Science       Date:  2015-11-19       Impact factor: 47.728

10.  SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1.

Authors:  Manuele Rebsamen; Lorena Pochini; Taras Stasyk; Mariana E G de Araújo; Michele Galluccio; Richard K Kandasamy; Berend Snijder; Astrid Fauster; Elena L Rudashevskaya; Manuela Bruckner; Stefania Scorzoni; Przemyslaw A Filipek; Kilian V M Huber; Johannes W Bigenzahn; Leonhard X Heinz; Claudine Kraft; Keiryn L Bennett; Cesare Indiveri; Lukas A Huber; Giulio Superti-Furga
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

View more
  12 in total

Review 1.  The "other" mTOR complex: New insights into mTORC2 immunobiology and their implications.

Authors:  Helong Dai; Angus W Thomson
Journal:  Am J Transplant       Date:  2019-03-19       Impact factor: 8.086

2.  T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions.

Authors:  Lee-Ann Van de Velde; Chitra Subramanian; Amber M Smith; Luke Barron; Joseph E Qualls; Geoffrey Neale; Adolfo Alfonso-Pecchio; Suzanne Jackowski; Charles O Rock; Thomas A Wynn; Peter J Murray
Journal:  J Biol Chem       Date:  2016-11-30       Impact factor: 5.157

Review 3.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 4.  Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity.

Authors:  Paulo C Rodriguez; Augusto C Ochoa; Amir A Al-Khami
Journal:  Front Immunol       Date:  2017-02-07       Impact factor: 7.561

Review 5.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

Review 6.  The role of mTOR-mediated signals during haemopoiesis and lineage commitment.

Authors:  Natasha Malik; Owen J Sansom; Alison M Michie
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

7.  Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.

Authors:  Jodie Hay; Kathryn Gilroy; Camille Huser; Anna Kilbey; Alma Mcdonald; Amanda MacCallum; Ailsa Holroyd; Ewan Cameron; James C Neil
Journal:  J Cell Biochem       Date:  2019-06-30       Impact factor: 4.429

8.  HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease.

Authors:  Sarah A Cook; William A Comrie; M Cecilia Poli; Morgan Similuk; Andrew J Oler; Aiman J Faruqi; Douglas B Kuhns; Sheng Yang; Alexander Vargas-Hernández; Alexandre F Carisey; Benjamin Fournier; D Eric Anderson; Susan Price; Margery Smelkinson; Wadih Abou Chahla; Lisa R Forbes; Emily M Mace; Tram N Cao; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Jordan S Orange; Geoffrey D E Cuvelier; Moza Al Hassani; Nawal Al Kaabi; Zain Al Yafei; Soma Jyonouchi; Nikita Raje; Jason W Caldwell; Yanping Huang; Janis K Burkhardt; Sylvain Latour; Baoyu Chen; Gehad ElGhazali; V Koneti Rao; Ivan K Chinn; Michael J Lenardo
Journal:  Science       Date:  2020-07-10       Impact factor: 47.728

9.  Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.

Authors:  E Kaitlynn Allen; Jeremy Chase Crawford; Lee-Ann Van de Velde; Taylor L Wilson; Clifford S Guy; Marion Russier; Leonie Zeitler; Armita Bahrami; David Finkelstein; Stephane Pelletier; Stacey Schultz-Cherry; Paul G Thomas; Peter J Murray
Journal:  Cancer Res       Date:  2021-07-23       Impact factor: 12.701

10.  Loss of Rictor in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice.

Authors:  Vladimir R Babaev; Jiansheng Huang; Lei Ding; Youmin Zhang; James M May; MacRae F Linton
Journal:  Front Immunol       Date:  2018-02-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.